Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
3
×
boston blog main
boston top stories
life sciences
national
3
×
national blog main
national top stories
new york blog main
san francisco blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
gene therapy
indiana blog main
indiana top stories
new york top stories
raleigh-durham blog main
raleigh-durham top stories
rna interference
san diego blog main
san diego top stories
san francisco top stories
sanofi
seattle blog main
seattle top stories
spark therapeutics
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2019
activism
acute hepatic porphyria
ambys medicines
amicus therapeutics
ampio pharmaceuticals
amy schulman
andreas klein
angelman syndrome
What
gene
therapy
3
×
aren’t
bio
drug
roundup
advanced
alnylam’s
approval
bff
car
conference
cutting
deals
developers
devoted
disease
drugs
easl
edge
experiments
fda
form
help
hot
imminent
interference
kicked
launch
liver
long
major
market
medicare
medicines
moves
news
noteworthy
patients
payers
Language
Current search:
national
×
therapy
×
" alnylam pharmaceuticals "
×
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
5 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”